CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)

This large, late-stage study is testing whether a new injectable medication called tozorakimab can help people with chronic obstructive pulmonary disease (COPD) who experience frequent symptom flare-ups. The trial will enroll over 1,400 adults who are already on standard inhaled …

This study is testing an investigational drug called tozorakimab to see if it can help people with a specific type of COPD. It aims to improve lung function, reduce the frequency of symptom flare-ups (exacerbations), and ease daily symptoms like breathlessness and cough. The tria…

This study follows 152 adults with COPD in Canada for six months after their doctor prescribes a specific triple-combination inhaler (BGF/Breztri). The goal is to see how this treatment affects their breathing symptoms, quality of life, and flare-ups in a real-world setting. Rese…

This study is testing whether two different doses of an injectable medication called tozorakimab can help people with COPD who frequently experience symptom flare-ups (exacerbations). Over 1,100 adults with moderate-to-severe COPD who are already on standard inhaler therapy will …

This study is testing whether a new injectable medication called tozorakimab can help people with COPD who keep having serious breathing flare-ups. About 1,172 adults who are former smokers and already on standard COPD inhalers will receive either the new drug or a placebo shot f…

This study is testing the long-term safety and effectiveness of an investigational drug called tozorakimab for people with chronic obstructive pulmonary disease (COPD). It is for adults with COPD who have a history of symptom flare-ups and previously completed one of two related …

This study is testing a new, simple way to screen for Chronic Obstructive Pulmonary Disease (COPD) using artificial intelligence (AI). Researchers are training an AI model to analyze short cough recordings from smartphones to see if it can accurately identify people who have COPD…

This pilot study tests whether providing air cleaners to high-risk COPD patients can reduce their exposure to wildfire smoke and prevent dangerous lung flare-ups. Researchers are working with 20 oxygen-dependent, non-smoking Kaiser Permanente patients aged 65+ who have frequent C…

This study is testing whether two common nutritional supplements—fish oil (n-3 PUFAs) and vitamin D—can help people with COPD who are losing weight and muscle, a condition called pulmonary cachexia. It will involve 45 participants and will measure changes in body weight, muscle m…

This study is testing whether adding electrical stimulation to leg muscles during standard pulmonary rehab helps people with COPD feel less short of breath and fatigued during activity, and more confident about exercising. It will involve 40 participants who have mild to severe C…

This study aims to understand how common bladder and urinary symptoms are in people with Chronic Obstructive Pulmonary Disease (COPD). Researchers will survey 30 adults with stable COPD to measure these symptoms and assess their knowledge about pelvic floor health. The goal is to…

This study aims to understand how Chronic Obstructive Pulmonary Disease (COPD) affects a person's ability to mentally visualize and feel movements. Researchers will compare 188 people with COPD to people without COPD using questionnaires and simple hand movement tests. The goal i…